Correlation analysis of the prognosis of HPV positive oropharyngeal cancer patients with T cell infiltration and neoantigen load
Received date: 2019-05-13
Revised date: 2019-07-23
Online published: 2019-08-05
Supported by
Supported by the National Natural Science Foundation of China(81772896);Supported by the National Natural Science Foundation of China(81630025);Supported by the National Natural Science Foundation of China(81602383);The Science and Technology Planning Project of Guangzhou City of China(2017004020102)
Oropharyngeal cancer is one type of head and neck squamous cell carcinoma that is commonly associated with human papillomavirus (HPV) infection. Its incidence is increasing year by year. However, in the clinical treatment, it is found that the overall prognosis of HPV positive oropharyngeal cancer patients is better than that of HPV negative patients. But till now, the underlying mechanism that leads to this phenomenon has not been fully elucidated. This research analyzed the immune cell infiltration and function, as well as neoantigen loads between HPV positive and negative patients by bioinformatic analysis using the TCGA database, and found that the overall survival rate of HPV positive patients was significantly higher than those in the HPV negative group. Analysis of the relative abundance of immune cells in tumor tissues showed that CD8 + T cells in HPV positive patients were significantly increased compared to those in HPV negative patients, and the expression levels of effector molecules, like IFN-γ and Granzyme B, were significantly upregulated. Meanwhile, the analysis of tumor neoantigen load (TNB) showed that the TNB of HPV positive patients was lower than that of the HPV negative group. This study provides some basic theoretical support for the treating HPV-related oropharyngeal cancer.
Huanzi Lu,Dikan Wang,Zhi Wang . Correlation analysis of the prognosis of HPV positive oropharyngeal cancer patients with T cell infiltration and neoantigen load[J]. Hereditas(Beijing), 2019 , 41(8) : 725 -735 . DOI: 10.16288/j.yczz.19-135
| [1] | Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML . Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med, 2016,375(19):1856-1867. | |||
| [2] | Shang W, Zheng JW . Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx. Chin J Oral Max Surg, 2018,16(06):533-546. | |||
| [2] | 尚伟, 郑家伟 . 口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读. 中国口腔颌面外科杂志, 2018,16(06):533-546. | |||
| [3] | Amornphimoltham P, Rechache K, Thompson J, Masedunskas A, Leelahavanichkul K, Patel V, Molinolo A, Gutkind JS, Weigert R . Rab25 regulates invasion and metastasis in head and neck cancer. Clin Cancer Res, 2013,19(6):1375-1388. | |||
| [4] | Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML . Human papillomavirus and rising oropharyngeal cancer incidence in the united states. J Clin Oncol, 2011,29(32):4294-4301. | |||
| [5] | Chi AC, Day TA, Neville BW . Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA-Cancer J Clin, 2015,65(5):401-421. | |||
| [6] | Clarke P, Radford K, Coffey M, Stewart M . Speech and swallow rehabilitation in head and neck cancer: united kingdom national multidisciplinary guidelines. J Laryngol Otol, 2016,130(S2):S176-S180. | |||
| [7] | Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, Wolfensberger M, Terracciano LM . P16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol, 2010,21(10):1961-1966. | |||
| [8] | Marur S, D'souza G, Westra WH, Forastiere AA . HPV- associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol, 2010,11(8):781-789. | |||
| [9] | Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst, 2008,100(4):261-269. | |||
| [10] | Lechner M, Frampton GM, Fenton T, Feber A, Palmer G, Jay A, Pillay N, Forster M, Cronin MT, Lipson D, Miller VA, Brennan TA, Henderson S, Vaz F, O'flynn P, Kalavrezos N, Yelensky R, Beck S, Stephens PJ, Boshoff C . Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV + and HPV- tumors . Genome Med, 2013,5(5):49. | |||
| [11] | Welters MJP, Ma W, Santegoets SJAM, Goedemans R, Ehsan I, Jordanova ES, van Ham VJ, van Unen V, Koning F, van Egmond SI, Charoentong
/
|